Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma, Medical Device Provisions Outlined In Korea, EU Free Trade Agreement

This article was originally published in The Pink Sheet Daily

Executive Summary

Fair, transparent, reasonable and non-discriminatory rules urged for pricing and reimbursement processes.

You may also be interested in...



South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig

HONG KONG - South Korea needs to clarify drug pricing regulations and speed up its decision-making process for new products if it hopes to attract, or even maintain, investment in the R&D pharmaceutical space

Industry Groups Make Anti-Kickback Pledge To Korean Health Industry

SEOUL - South Korean trade associations representing both multinational and local pharmaceutical companies told the government that their members will accept the government's new guidelines that classify meals provided to doctors and pharmacists worth more than KRW 100,000 ($80) as illegal kickbacks

Korea-EU Free Trade Agreement Creates Another Threat To Local Korean Pharmas; Good For MNCs

SEOUL - The conclusion of the Free Trade Agreement talks on July 13 with the European Union could deal another blow to generic-dependent local South Korean pharma companies, already hit by a similar pact pending with the U.S

Related Content

Topics

UsernamePublicRestriction

Register

PS068647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel